Russell Investments Group
CVAC

Russell Investments Group’s CureVac CVAC Stock Holding History

Russell Investments Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,753
Closed -$5.82K – 3713
2024
Q2 		$5.82K Hold
1,753
– – ﹤0.01% 3181
2024
Q1 		$5.39K Hold
1,753
– – ﹤0.01% 2935
2023
Q4 		$7.46K Hold
1,753
– – ﹤0.01% 2859
2023
Q3 		$11.6K Buy
+1,753
New +$15.5K ﹤0.01% 2968
2023
Q1 		– Sell
-1,205
Closed -$7.3K – 3307
2022
Q4 		$7.3K Hold
1,205
– – ﹤0.01% 2852
2022
Q3 		$9K Hold
1,205
– – ﹤0.01% 2866
2022
Q2 		$16K Buy
+1,205
New +$19.9K ﹤0.01% 2813

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group's CVAC Position: Q3 2024 in Review

Russell Investments Group sold out of CureVac (CVAC) in Q3 2024, closing a stake of 1,753 shares — an estimated $5.82K sold.

Russell Investments Group first reported a position in CVAC in Q2 2022 and held it in 7 quarters. The position peaked at $16K in Q2 2022. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Russell Investments Group reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 1,753 CureVac shares in Q3 2024, an estimated $5.82K.
  • Russell Investments Group first reported a position in CureVac in Q2 2022 and held it in 7 quarters.
  • Russell Investments Group's CureVac position peaked at $16K in Q2 2022.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.